University of Nebraska Medical Center · PharmacologyEdagwa Lab
Benson Edagwa · Omaha, Nebraska
Research Focus
Benson Edagwa's lab focuses on creating innovative, long-acting drug formulations for the treatment of pediatric patients with HIV-1. Their main goal is to develop a six-month injectable antiretroviral therapy that improves adherence to treatment. By using advanced drug delivery methods, they aim to overcome the limitations of daily oral therapies, making it easier for children to receive life-saving HIV treatment.
antiretroviral therapyprodrug formulationslong-acting therapeuticsHIV treatmentpediatric health
Research Aims
5AIM 01Develop a six-month injectable therapy for pediatric HIV patients.
AIM 02Enhance drug delivery methods to simplify treatment plans.
AIM 03Conduct toxicity and efficacy testing in relevant animal models.
AIM 04Formulate combined antiretroviral therapies into long-acting regimens.
AIM 05Improve adherence to HIV treatment by redesigning drug intake frequency.
Skills the Lab Values
formulation developmentinjectable drug preparationpharmacokinetic modelingtoxicology studiesin vitro testing
Output against the department
Publications91bottom 22% of dept.358th of 462
this lab
most publishedleast published
Citations3.4kbottom 26% of dept.343rd of 462
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.